• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Roche's Breast Cancer Franchise Boosted by Trial Data

Article

Roche, the world's biggest maker of cancer drugs, got a boost on Monday as results of trials that will protect sales of its breast cancer drug Herceptin coincided with data showing a new drug in the franchise helped patients live longer.

Two trials on Roche's blockbuster Herceptin wiped out a risk that they could have indicated a shorter period of treatment than the current recommendation of one year - a finding that could have cost up to $1.5 billion in sales.

Read the full story: http://reut.rs/W81x46

Source: Oncology Business Review

Related Videos
Danielle Roman, PharmD, BCOP, Allgheny Health Network
Dr Eric Yang
Drs Yelena Janjigian and Zev Wainberg | Background image credit: ipopba - stock.adobe.com
Nicoletta Colombo, MD, PhD
Oncology experts at PCOC
Joshua K. Sabari, MD
Joshua K. Sabari, MD
Nicoletta Colombo, MD, PhD
Dr Brian Mulherin
Related Content
© 2026 MJH Life Sciences
AJMC®
All rights reserved.